Novavax adamant its COVID shot will reach vaccine hesitant in Europe but wary of war’s impactnews2022-03-22T08:35:42+00:00March 22nd, 2022|Fierce Pharma|
After price deal, Takeda’s lung cancer drug Exkivity wins UK green light ahead of J&J rivalnews2022-03-21T16:33:49+00:00March 21st, 2022|Fierce Pharma|
After price deal, Takeda’s lung cancer drug Exkivity wins UK green lightnews2022-03-21T16:33:49+00:00March 21st, 2022|Fierce Pharma|
As AstraZeneca sounds the slowdown alarm in China, Jefferies beats the drum for growing branded drug marketnews2022-03-21T15:56:10+00:00March 21st, 2022|Fierce Pharma|
Recro Pharma rebrands itself as Societal CDMO in wake of Irisys purchasenews2022-03-21T14:43:44+00:00March 21st, 2022|Fierce Pharma|
Wockhardt, Serum Institute of India to build UK fill-finish plant in Walesnews2022-03-21T13:57:34+00:00March 21st, 2022|Fierce Pharma|
Cancer giants BMS, AstraZeneca clash in new checkpoint inhibitor patent suitnews2022-03-21T13:42:51+00:00March 21st, 2022|Fierce Pharma|
Eli Lilly CEO’s pay falls 9% to $21.5M—no thanks to pension declinesnews2022-03-21T11:43:37+00:00March 21st, 2022|Fierce Pharma|
Facing generic rivals, Ipsen starts $66M Somatuline autoinjector projectnews2022-03-21T08:46:10+00:00March 21st, 2022|Fierce Pharma|
Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic conditionnews2022-03-18T22:13:45+00:00March 18th, 2022|Fierce Pharma|
